Resveratrol structure and ceramide-associated growth inhibition in prostate cancer cells

Drugs under Experimental and Clinical Research

Volumn 29, Issue 5-6, 2003, Pages 263-269

  Sala, G ^a   Minutolo, F ^b   Macchia, M ^b   Sacchi, N ^a   Ghidoni, R ^a  

^a SAN PAOLO HOSPITAL   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3,4',5 TRIMETHOXYSTILBENE; ANDROGEN RECEPTOR; CERAMIDE; DRONABINOL; ETOPOSIDE; FENRETINIDE; HYDROXYL GROUP; PICEATANNOL; RESVERATROL; STILBENE; SULFORHODAMINE B; UNCLASSIFIED DRUG;

APOPTOSIS; BREAST CANCER; CANCER GROWTH; CANCER INHIBITION; CHEMOPROPHYLAXIS; CONFERENCE PAPER; CONTROLLED STUDY; DRUG STRUCTURE; GRAPE; HUMAN; HUMAN CELL; PEANUT; PROSTATE CANCER; WINE;

ANTICARCINOGENIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CERAMIDES; HUMANS; MALE; PROSTATIC NEOPLASMS; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP; TIME FACTORS;

EID: 2342557286     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. Bhat K.P., Pezzuto J.M. Cancer chemopreventive activity of resveratrol. Ann. N.Y. Acad. Sci., 957, 210, 2002.
2. Hsieh T.C., Wu J.M. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Exp. Cell. Res., 249, 109, 1999.
3. Schneider Y., Vincent F., Duranton B., et al. Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells. Cancer Lett. 158, 85-91, 2000.
4. Damianaki A., Bakogeorgou E., Kampa M., et al. Potent inhibitory action of red wine polyphenols on human breast cancer cells. J. Cell. Biochem., 78, 429, 2000.
5. Morris G.Z., Williams R.L., Elliott M.S., Beebe S.J. Resveratrol induces apoptosis in LNCaP cells and requires hydroxyl groups to decrease viability in LNCaP and DU 145 cells. Prostate, 52, 319, 2002.
6. Jang M., Cai L., Udeani G.O., et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 275, 218, 1997.
7. CIP expression. Carcinogenesis, 21, 1619, 2000.
8. Bhat K.P., Lantvit D., Christov K., et al. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res., 61, 7456, 2001.
9. Scarlatti F., Sala G., Somenzi G., et al. Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling. FASEB J., 17, 2339, 2003.
10. Hannun Y.A., Obeid L.M. The ceramide-centric universe of lipid-mediated cell regulation: Stress encounters of the lipid kind. J. Biol. Chem., 277, 25847, 2002.
11. Perry D.K., Carton J., Shah A.K., et al. Serine palmitoyl-transferase regulates de novo ceramide generation during etoposide-induced apoptosis. J. Biol. Chem., 275, 9078-9084, 2000.
12. Gómez del Pulgar T., Velasco G., Sánchez C., Haro A., Guzmán M. De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis. Biochem. J., 363, 183, 2002.
13. Wang H., Maurer B.J., Reynolds C.P., Cabot M.C. N-(4-hydroxyphenyl)retinamide elevates ceramide in neuroblastoma cell lines by coordinate activation of serine palmitoyltransferase and ceramide synthase. Cancer Res., 61, 5102, 2001.
14. Seelan R.S., Qian C., Yokomizo A., et al. Human acid ceramidase is overexpressed but not mutated in prostate cancer. Genes Chromosomes Cancer., 29, 137, 2000.
15. Wieder T., Prokop A., Bagci B., et al. Piceatannol, a hydroxylated analog of the chemopreventive agent resveratrol, is a potent inducer of apoptosis in the lymphoma cell line BJAB and in primary, leukemic lymphoblasts. Leukemia, 15, 1735, 2001.
16. Wolter F., Turchanowa L., Stein, J. Resveratrol-induced modification of polyamine metabolism is accompanied by induction of c-Fos. Carcinogenesis, 24, 469, 2003.
17. Schneider Y., Charbert P., Stutzmann J., et al. Resveratrol analog (Z)-3,5,4′-trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polimerization. Int. J. Cancer, 107, 189, 2003.